Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jack Nathan Medical (JNHMF)
OTHER OTC:JNHMF
Holding JNHMF?
Track your performance easily
JNHMF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.07
Previous Close$0.03
Volume11.00
Average Volume (3M)3.40K
Market Cap
$740.05K
Enterprise Value$9.66M
Total Cash (Recent Filing)C$768.01K
Total Debt (Recent Filing)C$13.22M
Price to Earnings (P/E)―
Beta-1.13
Next Earnings
Dec 19, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding87,099,159
10 Day Avg. Volume0
30 Day Avg. Volume3,400
Standard Deviation0.42
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.28
Price to Sales (P/S)0.12
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jack Nathan Medical News
PremiumCompany Announcements
Jack Nathan Health Posts Strong Q2 Revenue Growth
PremiumCompany Announcements
Jack Nathan Health Eyes Strategic Expansion
PremiumCompany Announcements
Jack Nathan Medical Secures Additional Funding
PremiumCompany Announcements
Jack Nathan Medical Announces Key Resignations
PremiumCompany Announcements
Jack Nathan Medical Shareholders Approve All Resolutions
PremiumCompany Announcements
Jack Nathan Medical Reports Strong Revenue GrowthPremiumCompany Announcements
Jack Nathan Health: Robust 25% Revenue Growth
PremiumCompany Announcements
Jack Nathan Medical Reports Strong Financial GrowthJNHMF FAQ
What was Jack Nathan Medical’s price range in the past 12 months?
Jack Nathan Medical lowest stock price was $0.01 and its highest was $0.07 in the past 12 months.
What is Jack Nathan Medical’s market cap?
Currently, no data Available
When is Jack Nathan Medical’s upcoming earnings report date?
Jack Nathan Medical’s upcoming earnings report date is Dec 19, 2024 which is in 26 days.
How were Jack Nathan Medical’s earnings last quarter?
Jack Nathan Medical released its earnings results on Sep 27, 2024. The company reported -$0.019 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.019.
Is Jack Nathan Medical overvalued?
According to Wall Street analysts Jack Nathan Medical’s price is currently Overvalued.
Does Jack Nathan Medical pay dividends?
Jack Nathan Medical does not currently pay dividends.
What is Jack Nathan Medical’s EPS estimate?
Jack Nathan Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jack Nathan Medical have?
Jack Nathan Medical has 41,349,160 shares outstanding.
What happened to Jack Nathan Medical’s price movement after its last earnings report?
Jack Nathan Medical reported an EPS of -$0.019 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Jack Nathan Medical?
Currently, no hedge funds are holding shares in JNHMF
---
Jack Nathan Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-8.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-46.46%
Trailing 12-Months
Company Description
Jack Nathan Medical
Jack Nathan Medical Corp is Canada's healthcare networks that designs, builds and sets-up barrier-free medical and dental clinics for physicians in high-density centers. The company is a healthcare company that is improving access for millions of patients by co-locating physician and ancillary medical services conveniently located inside Walmart stores. Jack Nathan Health provides an exceptional level of patient care, made possible through patient-centric physicians, a variety of medical services, technology and programs, designed to put patients first.
---
Technical Analysis
---